All Stories

  1. The Heparan Sulfate Proteoglycan Syndecan-1 Influences Local Bone Cell Communication via the RANKL/OPG Axis

    Article • November 2019, Cold Spring Harbor Laboratory Press

    Professor Martin Götte

  2. The Pathogenesis of Endometriosis: Molecular and Cell Biology Insights

    Article • International Journal of Molecular Sciences, November 2019, MDPI AG

    Prof. Antonio Simone Laganà, Professor Martin Götte

  3. γ‐Secretase inhibition affects viability, apoptosis, and the stem cell phenotype of endometriotic cells

    Article • Acta Obstetricia Et Gynecologica Scandinavica, September 2019, Wiley

    Professor Martin Götte

  4. Proteoglycans and glycosaminoglycans as regulators of cancer stem cell function and therapeutic resistance

    Article • FEBS Journal, June 2019, Wiley

    Professor Martin Götte

  5. The immunomodulatory role of tumor Syndecan-1 (CD138) on ex vivo tumor microenvironmental CD4+ T cell polarization in inflammatory and non-inflammatory breast cancer patients

    Article • PLoS ONE, May 2019, PLOS

    Professor Martin Götte

  6. Differentially-Expressed miRNAs in Ectopic Stromal Cells Contribute to Endometriosis Development: The Plausible Role of miR-139-5p and miR-375

    Article • International Journal of Molecular Sciences, November 2018, MDPI AG

    Professor Martin Götte

  7. The endometrial stem cell markers notch-1 and numb are associated with endometriosis

    Article • Reproductive BioMedicine Online, March 2018, Elsevier

    Professor Martin Götte

  8. Characterization of inflammatory breast cancer: a vibrational microspectroscopy and imaging approach at the cellular and tissue level

    Article • The Analyst, January 2018, Royal Society of Chemistry

    Professor Martin Götte

  9. Estrogen receptor beta as epigenetic mediator of miR-10b and miR-145 in mammary cancer

    Article • Matrix Biology, December 2017, Elsevier

    Professor Martin Götte

  10. Expression of PRL-3 regulates proliferation and invasion of breast cancer cells in vitro

    Article • Archives of Gynecology and Obstetrics, October 2017, Springer Science + Business Media

    Professor Martin Götte

  11. Challenges in endometriosis miRNA studies — From tissue heterogeneity to disease specific miRNAs

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, September 2017, Elsevier

    Professor Martin Götte

  12. Zebrafish Tmem230a cooperates with the Delta/Notch signaling pathway to modulate endothelial cell number in angiogenic vessels

    Article • Journal of Cellular Physiology, July 2017, Wiley

    Professor Martin Götte

  13. Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer

    Article • Matrix Biology, May 2017, Elsevier

    Professor Martin Götte

  14. Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways

    Article • Molecular Cancer, March 2017, Springer Science + Business Media

    Professor Martin Götte

  15. Stem Cell Trafficking During Endometriosis: May Epigenetics Play a Pivotal Role?

    Article • Reproductive Sciences, January 2017, SAGE Publications

    Prof. Antonio Simone Laganà, Professor Martin Götte

  16. RNA-Generated and Gene-Edited Induced Pluripotent Stem Cells for Disease Modeling and Therapy

    Article • Journal of Cellular Physiology, December 2016, Wiley

    Professor Martin Götte

  17. MDA-MB-231 breast cancer cell viability, motility and matrix adhesion are regulated by a complex interplay of heparan sulfate, chondroitin−/dermatan sulfate and hyaluronan biosynthesis

    Article • Glycoconjugate Journal, October 2016, Springer Science + Business Media

    Professor Martin Götte

  18. Shed proteoglycans in tumor stroma

    Article • Cell and Tissue Research, July 2016, Springer Science + Business Media

    Professor Martin Götte

  19. Faculty of 1000 evaluation for Estrogen receptor beta modulates breast cancer cells functional properties, signaling and expression of matrix molecules.

    Article • June 2016, Faculty of 1000, Ltd.

    Professor Martin Götte

  20. microRNA miR-200b affects proliferation, invasiveness and stemness of endometriotic cells by targeting ZEB1, ZEB2 and KLF4

    Article • Reproductive BioMedicine Online, April 2016, Elsevier

    Professor Martin Götte

  21. Prospects and challenges of quantitative phase imaging in tumor cell biology

    Article • March 2016, SPIE

    Professor Martin Götte

  22. Pathophysiologie der Endometriose

    Article • Gynäkologische Endokrinologie, January 2016, Springer Science + Business Media

    Professor Martin Götte

  23. Multi-Modal Quantitative Imaging of Genetically Modified Tumor Cells Utilizing Digital Holographic Microscopy

    Article • January 2016, Optical Society of America (OSA)

    Professor Martin Götte

  24. Physicochemical and biological characterization of chitosan-microRNA nanocomplexes for gene delivery to MCF-7 breast cancer cells

    Article • Scientific Reports, September 2015, Springer Science + Business Media

    Professor Martin Götte

  25. miR-142-3p is a novel regulator of cell viability and proinflammatory signalling in endometrial stroma cells

    Article • Reproductive BioMedicine Online, May 2015, Elsevier

    Professor Martin Götte

  26. Correlation between dioxin and endometriosis: an epigenetic route to unravel the pathogenesis of the disease

    Article • Archives of Gynecology and Obstetrics, April 2015, Springer Science + Business Media

    Prof. Antonio Simone Laganà, Professor Martin Götte

  27. Heparan Sulphate as a Regulator of Leukocyte Recruitment in Inflammation

    Article • Current Protein and Peptide Science, February 2015, Bentham Science Publishers

    Professor Martin Götte

  28. Impact of Extracellular Matrix on Cellular Behavior: A Source of Molecular Targets in Disease

    Article • BioMed Research International, January 2015, Hindawi Publishing Corporation

    Professor Martin Götte

  29. World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonisation Project: IV. Tissue collection, processing, and storage in endometriosis research

    Article • Fertility and Sterility, November 2014, Elsevier

    Professor Martin Götte

  30. World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonization Project: III. Fluid biospecimen collection, processing, and storage in endometriosis research

    Article • Fertility and Sterility, November 2014, Elsevier

    Professor Martin Götte

  31. MicroRNA regulation of proteoglycan function in cancer

    Article • FEBS Journal, November 2014, Wiley

    Professor Martin Götte

  32. The anti-androgen drug dutasteride renders triple negative breast cancer cells more sensitive to chemotherapy via inhibition of HIF-1α-/VEGF-signaling

    Article • Gynecological Endocrinology, October 2014, Taylor & Francis

    Professor Martin Götte

  33. Characteristics and Therapeutic Potential of Menstrual Blood-Derived Stem Cells

    Article • September 2014, Springer Science + Business Media

    Professor Martin Götte

  34. MicroRNA-dependent targeting of the extracellular matrix as a mechanism of regulating cell behavior

    Article • Biochimica et Biophysica Acta (BBA) - General Subjects, August 2014, Elsevier

    Professor Martin Götte

  35. Importance of Transvaginal Ultrasound Applying Elastography for Identifying Deep Infiltrating Endometriosis – A Feasibility Study

    Article • Ultraschall in der Medizin - European Journal of Ultrasound, July 2014, Thieme Publishing Group

    Professor Martin Götte

  36. HS3ST2 modulates breast cancer cell invasiveness via MAP kinase‐ and Tcf4 (Tcf7l2)‐dependent regulation of protease and cadherin expression

    Article • International Journal of Cancer, April 2014, Wiley

    Professor Martin Götte

  37. microRNA miR-200b differentially affects proliferation, invasiveness and stemness of endometriotic cells by targeting the transcription factors KLF4, ZEB1 and ZEB2

    Article • Experimental and Clinical Endocrinology & Diabetes, March 2014, Thieme Publishing Group

    Professor Martin Götte

  38. siRNA-mediated inhibition of the stemness-related Musashi pathway affects LIF receptor expression and prometastatic motility of human MDA-MB-231 breast cancer cells

    Article • Experimental and Clinical Endocrinology & Diabetes, March 2014, Thieme Publishing Group

    Professor Martin Götte

  39. Contribution of miR-218-dependent EGFR-signaling to the radiation response of breast cancer cells

    Article • Experimental and Clinical Endocrinology & Diabetes, March 2014, Thieme Publishing Group

    Professor Martin Götte

  40. Faculty Opinions recommendation of Endometriosis impairs bone marrow-derived stem cell recruitment to the uterus whereas bazedoxifene treatment leads to endometriosis regression and improved uterine stem cell engraftment.

    Article • February 2014, F1000Research

    Professor Martin Götte

  41. Influence of secreted frizzled receptor protein 1 (SFRP1) on neoadjuvant chemotherapy in triple negative breast cancer does not rely on WNT signaling

    Article • Molecular Cancer, January 2014, Springer Science + Business Media

    Professor Martin Götte

  42. Syndecan-1 (CD138) Modulates Triple-Negative Breast Cancer Stem Cell Properties via Regulation of LRP-6 and IL-6-Mediated STAT3 Signaling

    Article • PLoS ONE, December 2013, PLOS

    Professor Martin Götte

  43. Importance of transvaginal ultrasound elastography for identifying deep infiltrating endometriosis - a feasibility study

    Article • Ultraschall in der Medizin - European Journal of Ultrasound, October 2013, Thieme Publishing Group

    Professor Martin Götte

  44. Syndecan-1, a Cell Surface Proteoglycan, Negatively Regulates Initial Leukocyte Recruitment to the Brain across the Choroid Plexus in Murine Experimental Autoimmune Encephalomyelitis

    Article • The Journal of Immunology, September 2013, The American Association of Immunologists

    Professor Martin Götte

  45. A Versatile Tool for Stable Inhibition of microRNA Activity

    Article • Biology, June 2013, MDPI AG

    Professor Martin Götte

  46. Session 59: Endometrium

    Article • Human Reproduction, June 2013, Oxford University Press (OUP)

    Professor Martin Götte

  47. MicroRNA miR-145 inhibits proliferation, invasiveness, and stem cell phenotype of an in vitro endometriosis model by targeting multiple cytoskeletal elements and pluripotency factors

    Article • Fertility and Sterility, April 2013, Elsevier

    Professor Martin Götte

  48. Faculty Opinions recommendation of Circulating microRNAs identified in a genome-wide serum microRNA expression analysis as noninvasive biomarkers for endometriosis.

    Article • March 2013, F1000Research

    Professor Martin Götte

  49. Syndecan-1 modulates IL-6- and beta-integrin- dependent functions in breast cancer cell adhesion and migration

    Article • Experimental and Clinical Endocrinology & Diabetes, March 2013, Thieme Publishing Group

    Professor Martin Götte

  50. Syndecan-1 (CD138) modulates breast cancer stem cell properties via regulation of IL-6-mediated STAT3 signaling

    Article • Experimental and Clinical Endocrinology & Diabetes, March 2013, Thieme Publishing Group

    Professor Martin Götte

  51. Targeting of Syndecan-1 by microRNA miR-10b modulates invasiveness of endometriotic cells via dysregulation of IL-6 secretion and MAPK signaling

    Article • Experimental and Clinical Endocrinology & Diabetes, March 2013, Thieme Publishing Group

    Professor Martin Götte

  52. Pharmacological interference with the stemness-associated Notch-signaling pathway exerts an antiproliferative effect on the endometriotic 12Z cell line

    Article • Experimental and Clinical Endocrinology & Diabetes, March 2013, Thieme Publishing Group

    Professor Martin Götte

  53. microRNA miR-142 - 3 p is a novel regulator of cell viability and proinflammatory signaling in endometrial stroma cells

    Article • Experimental and Clinical Endocrinology & Diabetes, March 2013, Thieme Publishing Group

    Professor Martin Götte

  54. Specific sulfation patterns in heparan sulfate promote a proinvasive phenotype of breast cancer cells via upregulation of Wnt and MAPK signaling

    Article • Experimental and Clinical Endocrinology & Diabetes, March 2013, Thieme Publishing Group

    Professor Martin Götte

  55. Decorin Potentiates Interferon-  Activity in a Model of Allergic Inflammation

    Article • Journal of Biological Chemistry, March 2013, American Society for Biochemistry & Molecular Biology (ASBMB)

    Professor Martin Götte

  56. Targeting of syndecan-1 by micro-ribonucleic acid miR-10b modulates invasiveness of endometriotic cells via dysregulation of the proteolytic milieu and interleukin-6 secretion

    Article • Fertility and Sterility, March 2013, Elsevier

    Professor Martin Götte

  57. Syndecan‐1 modulates β‐integrin‐dependent and interleukin‐6‐dependent functions in breast cancer cell adhesion, migration, and resistance to irradiation

    Article • FEBS Journal, January 2013, Wiley

    Professor Martin Götte

  58. Cellular Microenvironment in Human Pathologies

    Article • BioMed Research International, January 2013, Hindawi Publishing Corporation

    Professor Martin Götte

  59. More than matrix: The multifaceted role of decorin in cancer

    Article • European Journal of Cell Biology, January 2013, Elsevier

    Professor Martin Götte

  60. Survivin, a target to modulate the radiosensitivity of Ewing’s sarcoma

    Article • Strahlentherapie und Onkologie, October 2012, Springer Science + Business Media

    Professor Martin Götte

  61. Faculty Opinions recommendation of A polymorphism in a let-7 microRNA binding site of KRAS in women with endometriosis.

    Article • June 2012, F1000Research

    Professor Martin Götte

  62. Die Sulfotransferase HS3ST2 moduliert MMP-Aktivität, Motilität und Invasivität von MDA-MB-231 Mammakarzinomzellen durch eine Aktivierung des Transkriptionsfaktors TCF4

    Article • Senologie - Zeitschrift für Mammadiagnostik und -therapie, June 2012, Thieme Publishing Group

    Professor Martin Götte

  63. mikroRNA-abhängiges ‚targeting‘ von Syndecan-1 verstärkt die Motilität und Invasivität von Mammakarzinomzellen durch Rho-GTPase- und E-cadherin-abhängige Mechanismen

    Article • Senologie - Zeitschrift für Mammadiagnostik und -therapie, June 2012, Thieme Publishing Group

    Professor Martin Götte

  64. Targeting of syndecan‐1 by microRNA miR‐10b promotes breast cancer cell motility and invasiveness via a Rho‐GTPase‐ and E‐cadherin‐dependent mechanism

    Article • International Journal of Cancer, May 2012, Wiley

    Professor Martin Götte

  65. Impact of testosterone on the expression of organic anion transporting polypeptides (OATP-1A2, OATP-2B1, OATP-3A1) in malignant and non-malignant human breast cells in vitro

    Article • Maturitas, April 2012, Elsevier

    Professor Martin Götte

  66. Flow cytometry in cancer stem cell analysis and separation

    Article • Cytometry Part A, February 2012, Wiley

    Professor Martin Götte

  67. Evaluation of placental syndecan‐1 expression in early pregnancy as a predictive fetal factor for pregnancy outcome

    Article • Prenatal Diagnosis, February 2012, Wiley

    Professor Martin Götte

  68. Faculty Opinions recommendation of Role of label-retaining cells in estrogen-induced endometrial regeneration.

    Article • January 2012, F1000Research

    Professor Martin Götte

  69. MicroRNAs and the pathogenesis of endometriosis

    Article • Journal of Endometriosis, January 2012, Wichtig

    Professor Martin Götte

  70. Cell Adhesion in Cancer

    Article • International Journal of Cell Biology, January 2012, Hindawi Publishing Corporation

    Professor Martin Götte

  71. Stammzellen (SZ) und Regeneration des Endometriums – was wissen wir wirklich?

    Article • Geburtshilfe und Frauenheilkunde, November 2011, Thieme Publishing Group

    Professor Martin Götte

  72. The Role for Decorin in Delayed-Type Hypersensitivity

    Article • The Journal of Immunology, October 2011, The American Association of Immunologists

    Professor Martin Götte

  73. 2030 POSTER Knockdown of the Apoptosis Related Protein Survivin Leads to an Increased Radiosensitivity of Ewing Sarcoma in Vitro

    Article • European Journal of Cancer, September 2011, Elsevier

    Professor Martin Götte

  74. Effects of the FSH receptor gene polymorphism p.N680S on cAMP and steroid production in cultured primary human granulosa cells

    Article • Reproductive BioMedicine Online, August 2011, Elsevier

    Manuela Simoni, Professor Martin Götte

  75. mikroRNAs als neue therapeutische Zielstrukturen der Endometriose

    Article • Geburtshilfe und Frauenheilkunde, August 2011, Thieme Publishing Group

    Professor Martin Götte

  76. Faculty Opinions recommendation of Syndecan-1 regulates alphavbeta3 and alphavbeta5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor.

    Article • July 2011, F1000Research

    Professor Martin Götte

  77. Antiandrogene Therapie als eine neue Behandlungsoption beim tripelnegativen Mammakarzinom (TNBC)

    Article • Senologie - Zeitschrift für Mammadiagnostik und -therapie, May 2011, Thieme Publishing Group

    Professor Martin Götte

  78. mikroRNAs als neue therapeutische Zielstrukturen der Endometriose – Regulation der Motilität und Proliferation von Endometriosezellen durch miR-145 und miR-10b

    Article • Geburtshilfe und Frauenheilkunde, May 2011, Thieme Publishing Group

    Professor Martin Götte

  79. Der wnt-Signalweg als potentieller Biomarker für das tripelnegative Mammakarzinom

    Article • Senologie - Zeitschrift für Mammadiagnostik und -therapie, May 2011, Thieme Publishing Group

    Professor Martin Götte

  80. The adult stem cell marker Musashi‐1 modulates endometrial carcinoma cell cycle progression and apoptosis via Notch‐1 and p21WAF1/CIP1

    Article • International Journal of Cancer, March 2011, Wiley

    Professor Martin Götte

  81. Faculty Opinions recommendation of Human endometrial cells express elevated levels of pluripotent factors and are more amenable to reprogramming into induced pluripotent stem cells.

    Article • February 2011, F1000Research

    Professor Martin Götte

  82. Heparan Sulfate Proteoglycans in Cancer Therapy

    Article • January 2011, Springer Science + Business Media

    Professor Martin Götte, Ezeddin Gassar

  83. Characterization of endometrial mesenchymal stem-like cells obtained by endometrial biopsy during routine diagnostics

    Article • Fertility and Sterility, January 2011, Elsevier

    Professor Martin Götte

  84. Aberrant expression of the pluripotency marker SOX-2 in endometriosis

    Article • Fertility and Sterility, January 2011, Elsevier

    Professor Martin Götte

  85. mRNA-Expression of ERα, ERβ, and PR in Clonal Stem Cell Cultures Obtained from Human Endometrial Biopsies

    Article • The Scientific World JOURNAL, January 2011, Hindawi Publishing Corporation

    Professor Martin Götte

  86. Faculty Opinions recommendation of Immunohistochemical evaluation of endometriotic lesions and disseminated endometriosis-like cells in incidental lymph nodes of patients with endometriosis.

    Article • November 2010, F1000Research

    Professor Martin Götte

  87. Syndecan-1 knock-down in decidualized human endometrial stromal cells leads to significant changes in cytokine and angiogenic factor expression patterns

    Article • Reproductive Biology and Endocrinology, November 2010, Springer Science + Business Media

    Professor Martin Götte

  88. miR-145-dependent targeting of Junctional Adhesion Molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness

    Article • Oncogene, September 2010, Springer Science + Business Media

    Professor Martin Götte

  89. Multitargeted therapies: Kombinierter Einsatz von Trastuzumab und ECE-1-Inhibitoren beim Mammakarzinom

    Article • Senologie - Zeitschrift für Mammadiagnostik und -therapie, June 2010, Thieme Publishing Group

    Professor Martin Götte

  90. Bedeutung von MMP-2, MMP-9 & MMP-3 für die ET-1/ETAR-vermittelten Invasion humaner Mammakarzinomzellen

    Article • Senologie - Zeitschrift für Mammadiagnostik und -therapie, June 2010, Thieme Publishing Group

    Professor Martin Götte

  91. Targeting endothelin A receptor enhances anti‐proliferative and anti‐invasive effects of the HER2 antibody trastuzumab in HER2‐overexpressing breast cancer cells

    Article • International Journal of Cancer, May 2010, Wiley

    Professor Martin Götte

  92. Endometrial Cells Get Side-Tracked

    Article • American Journal Of Pathology, January 2010, Elsevier

    Professor Martin Götte

  93. Enoxaparin Improves the Course of Dextran Sodium Sulfate-Induced Colitis in Syndecan-1-Deficient Mice

    Article • American Journal Of Pathology, January 2010, Elsevier

    Professor Martin Götte

  94. Overlapping Genes May Control Reprogramming of Mouse Somatic Cells into Induced Pluripotent Stem Cells (iPSCs) and Breast Cancer Stem Cells

    Article • In Silico Biology, January 2010, IOS Press

    Professor Martin Götte

  95. ETAR antagonist ZD4054 exhibits additive effects with aromatase inhibitors and fulvestrant in breast cancer therapy, and improves in vivo efficacy of anastrozole

    Article • Breast Cancer Research and Treatment, November 2009, Springer Science + Business Media

    Professor Martin Götte

  96. Effect of testosterone on E1S-sulfatase activity in non-malignant and cancerous breast cells in vitro

    Article • The Journal of Steroid Biochemistry and Molecular Biology, November 2009, Elsevier

    Professor Martin Götte

  97. Role of syndecan-3 polymorphisms in obesity and female hyperandrogenism

    Article • Journal of Molecular Medicine, October 2009, Springer Science + Business Media

    Professor Martin Götte

  98. Sirna-targeting of the adult progenitor cell marker Musashi-1 leads to a modulation of cell cycle progression and apoptosis in endometrial carcinoma cells

    Article • Fertility and Sterility, September 2009, Elsevier

    Professor Martin Götte

  99. Stammzellen im Endometrium

    Article • Gynäkologische Endokrinologie, August 2009, Springer Science + Business Media

    Professor Martin Götte

  100. Einfluss der Protein-Tyrosin-Phosphatase PRL-3 auf das Proliferations-, Migrations- und Invasionsverhalten von Mammakarzinomzellen in vitro

    Article • Senologie - Zeitschrift für Mammadiagnostik und -therapie, May 2009, Thieme Publishing Group

    Professor Martin Götte

  101. Role of the Heparan Sulfate Proteoglycan Syndecan-1 (CD138) in Delayed-Type Hypersensitivity

    Article • The Journal of Immunology, April 2009, The American Association of Immunologists

    Professor Martin Götte

  102. Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression

    Article • Carcinogenesis, January 2009, Oxford University Press (OUP)

    Professor Martin Götte

  103. Die plazentare Syndecan–1 Expression im 1. und frühen 2. Trimenon: Ein prädiktiver Faktor für das Schwangerschaftsoutcome?

    Article • Geburtshilfe und Frauenheilkunde, September 2008, Thieme Publishing Group

    Professor Martin Götte

  104. In vitro-Studien zu Interaktionen zwischen VEGF- und Endothelin-System in humanen Mammakarzinom-Zelllinien

    Article • Geburtshilfe und Frauenheilkunde, September 2008, Thieme Publishing Group

    Professor Martin Götte

  105. Einfluss von Testosteron, Tibolon und Cimicifuga racemosa auf gereinigte 17ß-HSD 1 aus humaner Plazenta und Brustgewebe

    Article • Geburtshilfe und Frauenheilkunde, September 2008, Thieme Publishing Group

    Professor Martin Götte

  106. Specific endothelin-A-receptor antagonist ZD4054 inhibits breast cancer growth in vitro and in vivo

    Article • Geburtshilfe und Frauenheilkunde, September 2008, Thieme Publishing Group

    Professor Martin Götte

  107. Erhöhte Expression des Stammzellmarkers Musashi–1 bei proliferativen Erkrankungen des Endometriums – Potentielle Bedeutung für die Pathogenese von Endometriose und Endometriumkarzinom

    Article • Geburtshilfe und Frauenheilkunde, September 2008, Thieme Publishing Group

    Professor Martin Götte

  108. Molekularer Cross-talk zwischen dem HER- und dem Endothelin (ET)-System beim Mammakarzinom in vitro: Therapeutische Nutzung durch eine kombinierte zielgerichtete anti-HER/ETAR-Therapie

    Article • Senologie - Zeitschrift für Mammadiagnostik und -therapie, September 2008, Thieme Publishing Group

    Professor Martin Götte

  109. Increased expression of the adult stem cell marker Musashi‐1 in endometriosis and endometrial carcinoma

    Article • The Journal of Pathology, May 2008, Wiley

    Professor Martin Götte

  110. Einfluss von Testosteron und Tibolon auf gereinigte 17beta-HSD 1 aus humaner Plazenta und Brustgewebe

    Article • Geburtshilfe und Frauenheilkunde, March 2008, Thieme Publishing Group

    Professor Martin Götte

  111. Erhöhte Expression des Stammzellmarkers Musashi-1 im Kontext von Endometriose und Endometriumkarzinom

    Article • Geburtshilfe und Frauenheilkunde, March 2008, Thieme Publishing Group

    Professor Martin Götte

  112. Autokrine Interaktionen zwischen VEGF- und Endothelin-System in humanen Mammakarzinom-Zelllinien

    Article • Geburtshilfe und Frauenheilkunde, March 2008, Thieme Publishing Group

    Professor Martin Götte

  113. Bedeutung der Protein-Tyrosin-Phosphatase PRL-3 für das Invasionsverhalten von Mammakarzinom-Zellen

    Article • Geburtshilfe und Frauenheilkunde, March 2008, Thieme Publishing Group

    Professor Martin Götte

  114. Die lösliche Form des prognostischen Markers Syndecan-1 fördert die Invasivität von Mammakarzinomzellen durch einen TIMP-1- und E-Cadherin-abhängigen Mechanismus

    Article • Geburtshilfe und Frauenheilkunde, March 2008, Thieme Publishing Group

    Professor Martin Götte

  115. ZD4054, ein selektiver Endothelin-A-Rezeptor-Antagonist, reduziert die Invasion von Brustkrebszellen und zeigt synergistische Effekte mit Aromataseinhibitoren und Fulvestrant

    Article • Geburtshilfe und Frauenheilkunde, March 2008, Thieme Publishing Group

    Professor Martin Götte

  116. Effects of hormone therapy on estrogen synthesis from E1S in the mammary gland of postmenopausal women

    Article • Maturitas, February 2008, Elsevier

    Professor Martin Götte

  117. Syndecan-1 deficiency aggravates anti-glomerular basement membrane nephritis

    Article • Kidney International, November 2007, Elsevier

    Professor Martin Götte

  118. Effects of black cohosh on estrogen biosynthesis in normal breast tissue in vitro

    Article • Maturitas, August 2007, Elsevier

    Professor Martin Götte

  119. Enoxaparin verbessert den Verlauf der murinen DSS Colitis in Syndecan-1 defizienten Mäusen

    Article • Seminars in Musculoskeletal Radiology, August 2007, Thieme Publishing Group

    Professor Martin Götte

  120. Endothelin Receptor Type B Counteracts Tenascin-C–Induced Endothelin Receptor Type A–Dependent Focal Adhesion and Actin Stress Fiber Disorganization

    Article • Cancer Research, July 2007, American Association for Cancer Research (AACR)

    Professor Martin Götte

  121. Differential effect of hormone therapy on E1S-sulfatase activity in non-malignant and cancerous breast cells in vitro

    Article • Breast Cancer Research and Treatment, June 2007, Springer Science + Business Media

    Professor Martin Götte

  122. Additive Proliferationshemmung humaner Mammakarzinomzellen durch Trastuzumab und Atrasentan

    Article • Senologie - Zeitschrift für Mammadiagnostik und -therapie, June 2007, Thieme Publishing Group

    Professor Martin Götte

  123. Selektiver ETAR-Antagonismus verhindert die Hypoxie-induzierte Invasion von Brustkrebszellen

    Article • Senologie - Zeitschrift für Mammadiagnostik und -therapie, June 2007, Thieme Publishing Group

    Professor Martin Götte

  124. Expression von PRL-3 in Primärtumoren von Mammakarzinom-Patientinnen mit und ohne Nachweis disseminierter Tumorzellen im Knochenmark

    Article • Senologie - Zeitschrift für Mammadiagnostik und -therapie, June 2007, Thieme Publishing Group

    Professor Martin Götte

  125. Endocytosis of the dermatan sulfate proteoglycan decorin utilizes multiple pathways and is modulated by epidermal growth factor receptor signaling

    Article • Biochimie, May 2007, Elsevier

    Professor Martin Götte

  126. Selective ETAR antagonist atrasentan inhibits hypoxia-induced breast cancer cell invasion

    Article • Breast Cancer Research and Treatment, April 2007, Springer Science + Business Media

    Professor Martin Götte

  127. Die Endothelin-Achse: ein neues molekulares “Target“ für die Therapie des Mammakarzinoms

    Article • Geburtshilfe und Frauenheilkunde, April 2007, Thieme Publishing Group

    Professor Martin Götte

  128. Einfluss von Trastuzumab auf die Expression der Endothelin-Achse in humanen Mammakarzinom-Zelllinien

    Article • Geburtshilfe und Frauenheilkunde, April 2007, Thieme Publishing Group

    Professor Martin Götte

  129. Co-Expression von Endothelin-1 und Endothelin-A-Rezeptor mit der Cyclooxygenase-2 beim Mammakarzinom

    Article • Geburtshilfe und Frauenheilkunde, April 2007, Thieme Publishing Group

    Professor Martin Götte

  130. Selektive Hemmung des Endothelin-A-Rezeptors (ETAR) reduziert die Hypoxie-induzierte Invasivität von Brustkrebszellen

    Article • Geburtshilfe und Frauenheilkunde, April 2007, Thieme Publishing Group

    Professor Martin Götte

  131. Assoziation einer Expressionssignatur von Syndecan-1 (CD138), E-Cadherin und c-Met mit Angiogenese- und Lymphangiogenesefaktoren beim duktalen Karzinom in situ

    Article • Geburtshilfe und Frauenheilkunde, April 2007, Thieme Publishing Group

    Professor Martin Götte

  132. Differentieller Einfluss membrangebundener und löslicher Formen von Syndecan-1 (CD138) auf die Proliferation und Invasivität von Mammakarzinomzellen in vitro

    Article • Geburtshilfe und Frauenheilkunde, April 2007, Thieme Publishing Group

    Professor Martin Götte

  133. On the role of endothelin-converting enzyme-1 (ECE-1) and neprilysin in human breast cancer

    Article • Breast Cancer Research and Treatment, February 2007, Springer Science + Business Media

    Professor Martin Götte

  134. Increased Expression of Syndecan-1 Protects Against Cardiac Dilatation and Dysfunction After Myocardial Infarction

    Article • Circulation, January 2007, Wolters Kluwer Health

    Professor Martin Götte

  135. An expression signature of syndecan-1 (CD138), E-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in situ

    Article • January 2007, Springer Science + Business Media

    Professor Martin Götte

  136. Heparanase, Hyaluronan, and CD44 in Cancers: A Breast Carcinoma Perspective

    Article • Cancer Research, November 2006, American Association for Cancer Research (AACR)

    Professor Martin Götte

  137. Divide or unite—a novel molecular switch in endometrial carcinoma

    Article • Journal of Molecular Medicine, October 2006, Springer Science + Business Media

    Professor Martin Götte

  138. Therapeutic value of glycosaminoglycans in cancer

    Article • Molecular Cancer Therapeutics, September 2006, American Association for Cancer Research (AACR)

    Professor Martin Götte

  139. Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer

    Article • British Journal of Cancer, July 2006, Springer Science + Business Media

    Professor Martin Götte

  140. Defective glycosylation of decorin and biglycan, altered collagen structure, and abnormal phenotype of the skin fibroblasts of an Ehlers–Danlos syndrome patient carrying the novel Arg270Cys substitution in galactosyltransferase I (β4GalT-7)

    Article • Journal of Molecular Medicine, April 2006, Springer Science + Business Media

    Professor Martin Götte

  141. A Novel 110-kDa Receptor Protein is Involved in Endocytic Uptake of Decorin by Human Skin Fibroblasts

    Article • The Scientific World JOURNAL, January 2006, Hindawi Publishing Corporation

    Professor Martin Götte

  142. Metformin alters insulin signaling and viability of human granulosa cells

    Article • Fertility and Sterility, October 2005, Elsevier

    Professor Martin Götte

  143. Constitutive and Accelerated Shedding of Murine Syndecan-1 Is Mediated by Cleavage of Its Core Protein at a Specific Juxtamembrane Site

    Article • Biochemistry, August 2005, American Chemical Society (ACS)

    Professor Martin Götte

  144. The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages

    Article • Journal of Clinical Investigation, August 2005, American Society for Clinical Investigation

    Professor Martin Götte

  145. Overexpression of Endothelin-A-receptor in breast cancer: Regulation by estradiol and cobalt-chloride induced hypoxia

    Article • International Journal of Oncology, April 2005, Spandidos Publications

    Professor Martin Götte

  146. Defective Glycosaminoglycan Substitution of Decorin in a Patient With Progeroid Syndrome Is a Direct Consequence of Two Point Mutations in the Galactosyltransferase I (�4galT-7) Gene

    Article • Biochemical Genetics, February 2005, Springer Science + Business Media

    Professor Martin Götte

  147. Increased Leukocyte-Endothelial Interactions in Syndecan-1–Deficient Mice Involve Heparan Sulfate–Dependent and –Independent Steps

    Article • Current Eye Research, January 2005, Taylor & Francis

    Professor Martin Götte

  148. Heparan Sulfate Structure in Mice with Genetically Modified Heparan Sulfate Production

    Article • Journal of Biological Chemistry, July 2004, American Society for Biochemistry & Molecular Biology (ASBMB)

    Professor Martin Götte

  149. Inhibition by the Soluble Syndecan-1 Ectodomains Delays Wound Repair in Mice Overexpressing Syndecan-1

    Article • Journal of Biological Chemistry, June 2004, American Society for Biochemistry & Molecular Biology (ASBMB)

    Professor Martin Götte

  150. Age-Related Molecular Polymorphism of the Heterodimeric Proteoglycan Bisdermican

    Article • The Scientific World JOURNAL, January 2004, Hindawi Publishing Corporation

    Professor Martin Götte

  151. Syndecans in inflammation

    Article • The FASEB Journal, April 2003, Federation of American Societies For Experimental Biology (FASEB)

    Professor Martin Götte

  152. Syndecan-1 as a Regulator of Chemokine Function

    Article • The Scientific World JOURNAL, January 2003, Hindawi Publishing Corporation

    Professor Martin Götte

  153. Screening for suppressors of temperature sensitivity in a yeast mutant defective in vacuolar protein degradation

    Article • Genetics and Molecular Biology, January 2003, FapUNIFESP (SciELO)

    Professor Martin Götte

  154. Heterologous Expression of Syntaxin 6 in Saccharomyces cerevisiae

    Article • Biological Research, January 2002, SciELO Comision Nacional de Investigacion Cientifica Y Tecnologica (CONICYT)

    Professor Martin Götte

  155. Functions of Cell Surface Heparan Sulfate Proteoglycans

    Article • Annual Review of Biochemistry, June 1999, Annual Reviews

    Professor Martin Götte

  156. The ins and outs of yeast vacuole trafficking

    Article • PROTOPLASMA, March 1999, Springer Science + Business Media

    Professor Martin Götte

  157. A new beat for the SNARE drum

    Article • Trends in Cell Biology, June 1998, Elsevier

    Professor Martin Götte

  158. Vesicular transport: how many Ypt/Rab-GTPases make a eukaryotic cell?

    Article • Trends in Biochemical Sciences, December 1997, Elsevier

    Professor Martin Götte

  159. High expression of the yeast syntaxin‐related Vam3 protein suppresses the protein transport defects of a pep12 null mutant

    Article • FEBS Letters, July 1997, Wiley

    Professor Martin Götte

  160. The Full Complement of Yeast Ypt/Rab-GTPases and Their Involvement in Exo- and Endocytic Trafficking

    Article • Springer Science + Business Media

    Professor Martin Götte